Hormone replacement therapy and malignant melanoma: To prescribe or not to prescribe?

Climacteric

Volumn 5, Issue 2, 2002, Pages 197-200

  Durvasula, R ^a   Ahmed, S M ^a   Vashisht, A ^a   Studd, J W W ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Hormone replacement therapy; Melanoma

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; VINDESINE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MELANOMA; MENOPAUSE; ONSET AGE; ORAL CONTRACEPTION; PREGNANCY COMPLICATION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT INDICATION; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; HYSTERECTOMY; LEG; METASTASIS; MIDDLE AGED; OVARIECTOMY; PATHOLOGY; REVIEW; SKIN TUMOR; TUMOR RECURRENCE;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYSTERECTOMY; LEG; MELANOMA; MENOPAUSE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIECTOMY; PHYSICIAN'S PRACTICE PATTERNS; SKIN NEOPLASMS;

EID: 0036001277     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.5.2.197.200     Document Type: Article

References (28)

1. Cutaneous malignant melanoma in Scotland: Incidence, survival, and mortality, 1979-94
2. Diagnosis and management of malignant melanoma
3. Surgical progress and understanding in the treatment of the melanoma epidemic
4. Is malignant melanoma an endocrine-dependent tumor? The possible adverse effect of estrogen
5. Malignant melanoma
6. Adverse effect of pregnancy on melanoma: A reappraisal
7. Studies on melanoma: II. Sex and survivial in human melanoma: A reappraisal
8. Malignant melanoma and oral contraceptive use among women in California
9. Oral contraceptive use and malignant melanoma
10. Cutaneous melanoma in women: Ovulatory life, menopause, and use of exogenous estrogens
11. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - Long-term follow-up of a Swedish cohort
12. Cutaneous melanoma in relation to exogenous hormones and reproductive factors
13. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women
14. Reproductive factors, oral contraceptives, and risk of malignant melanoma: Western Canada Melanoma Study
15. Cutaneous malignant melanoma in women: Exogenous sex hormones and reproductive factors
16. Oral contraceptive use and malignant melanoma in Australia
17. Oestrogen receptors in human malignant melanoma
18. Inhibition of imidazole-induced tyrosinase activity by estradiol and estriol in cultured B16/C3 melanoma cells
19. Skin pigmentation in relation to the menstrual cycle
20. Estrogen receptor in malignant melanoma
21. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice
22. Melanotic adenocarcinoma of the uterus. Neuroendocrine tumor of the uterus
23. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody
24. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: Absence of immunohistochemically detectable hormone receptors
25. Absence of estrogen receptors in dysplastic nevi and malignant melanoma
26. Pregnancy and exogenous hormones in patients with cutaneous malignant melanoma
27. Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature
28. Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma